RNA Formulation Resources

1. Lipid Nanoparticle Compositional Analysis By UHPLC-CAD 6/30/2023

   Explore results generated from an internal study using a proprietary mRNA-LNP formulation and UHPLC-CAD, a powerful technique for the analysis of compounds that do not contain chromophores.

2. Mixing Technology: Linear Scalability And Mixing Precision For Nanoparticle Formulation 8/5/2025

   Find out how you can achieve precise control and linear scalability in nanoparticle formulation with mixing technology that minimizes batch-to-batch variability and simplifies the scale-up process.

3. The Heroes Of Vaccine Development: Lipid Nanoparticles 2/8/2024

   Lipid nanoparticles (LNPs) have played a crucial role in COVID-19 vaccine development as efficient mRNA delivery systems, exhibiting versatility and effectiveness in accelerating the process.

4. Formulation Process And Analytical Development Capabilities 3/25/2024

   Explore process and analytical development capabilities that can help you advance your formulation to GMP Manufacturing.

5. Expectations On The Pathway To GMP For Gene-Modified Cell Therapies 6/21/2023

   Learn how a robust understanding of the RNP’s critical process parameters and CQAs is crucial for ensuring product consistency, enhancing patient safety, and maintaining regulatory compliance.

6. Continuous Nanoparticle Manufacturing For Gene Editing Delivery 9/18/2025

   Messenger RNA-LNPs are a promising strategy for delivering gene-editing components. Learn how a continuous manufacturing platform can address the scalability and reproducibility challenges of this process.

7. Drug Discovery And Screening, A Digital Era For RNA-LNP Therapeutics 11/21/2022

   Learn about the key stages of drug discovery and screening as well as how to overcome bottlenecks in screening mRNA-LNPs to rapidly develop genomic medicines.

8. Hemophilia - Global Clinical Trial Landscape 11/7/2023

   Delve into the clinical landscape of hemophilia, a rare X-linked congenital bleeding disorder, across three key regions of the globe, namely Asia Pacific, Europe, and North America.

9. Standardize Scale-Up And Reduce Time To Market With Mixing Cartridges 7/21/2023

   Despite the momentum of the RNA-LNP therapeutic market, significant manufacturing challenges remain. However, the right mixing could solve three of these key challenges regarding instrumentation.

10. Potent Immune Response With Vernal's LNP-mRNAs 4/26/2024

    As mRNA medicine continues to evolve, understand how trusted manufacturing partners will continue to play a pivotal role in translating innovative concepts into clinical reality.